Motivation, expectation of success negate obviousness presumption in overlapping range case

Start
The US Court of Appeals for the Federal Circuit affirmed (on its second review) a district court’s ruling upholding the validity of patent claims related to a long-acting injectable dosing regimen, finding that the presumption of obviousness does not apply automatically and must be grounded in specific factual findings, particularly regarding a skilled artisan’s motivation and expectations. Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Case No. 25-1228 (Fed. Cir. July 8, 2025)…
By: McDermott Will & Emery
Previous Story

Appeal is too late to raise percolating claim construction dispute

Next Story

Cybersecurity Regulation in Flux as Trump Administration Focuses on Evolving Foreign and Tech Threats